Metoclopramide, an FDA-approved prokinetic for gastroparesis, carries a boxed warning for tardive dyskinesia and should generally be limited to 12 weeks or less of therapy
All treatments are administered by highly trained and qualified licensed medical staff
Tirzepatide is injected subcutaneously into the abdomen, the upper outer thigh, or the back of the upper arm
Microglia, the resident immune cells in the CNS, function as brain macrophages and are essential in modulating neuroinflammation when activated under inflammatory conditions [100, 101]
It is not approved for human use, veterinary use, therapeutic use, diagnostic use, or clinical application